United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al ittihad drug store germany - 250ml bottle - infusion - 400mg/250ml - infections-antibacterial

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al ittihad drug store united arab emirates - 250 ml ldpe bottle - infusion - 400 mg/250 ml - infections-antibacterial

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmalink store italy - 250ml bottle - solution - 125g/250ml - gastrointestinal system-laxatives

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gaelan medical trade l.l.c greece - 250 ml plastic bottle - solution - 0.8% / 250 ml - medical devices-medical devices

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gaelan medical trade l.l.c greece - 250 ml plastic bottle - solution - 1.5 % / 250ml - medical devices-medical devices

United States - English - NLM (National Library of Medicine)

dr.reddys laboratories limited - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine 250 mg - terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).   prior to initiating treatment, appropriate nail specimens for laboratory testing (koh preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets are contraindicated in individuals with a history of allergic reaction to oral terbinafine because of the risk of anaphylaxis. pregnancy category b: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, and because treatment of onychomycosis can be postponed until after pregnancy is completed, it is recommended that terbinafine hydrochloride not be initiated during pregnancy.   oral reproduction studies have been performed in rabbits and rats at doses up to 300 mg/kg/day (12x to 23x the mrhd, in rabbits and rats, respectively, based on bsa) and have revealed no evidence

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - atovaquone, quantity: 250 mg; proguanil hydrochloride, quantity: 100 mg - tablet - excipient ingredients: povidone; microcrystalline cellulose; poloxamer; sodium starch glycollate type a; hyprolose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 8000; iron oxide red; macrogol 400 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults.,? treatment of plasmodium falciparum malaria in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - 250mg/100mg - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: hyprolose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose opadry pink oy-s-24972 poloxamer 188 povidone sodium starch glycolate

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - terbinafine hydrochloride, quantity: 281.3 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: methylcellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - apo-terbinafine is indicated for: treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infections caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa sesquihydrate, quantity: 283 mg (equivalent: methyldopa, qty 250 mg) - tablet, film coated - excipient ingredients: ethylcellulose; disodium edetate; magnesium stearate; guar gum; sodium starch glycollate; colloidal anhydrous silica; citric acid; titanium dioxide; hypromellose; sunset yellow fcf; quinoline yellow; macrogol 400 - indications as at 7 may 1996: hypertension (mild, moderate to severe)